AtriCure, Inc. (ATRC) Stock News, Earnings & History

(NASDAQ:ATRC) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 9.98
52wk low: 5.90
EPS: -0.46
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 190.89M
Avg Vol (3m): 65,303

Latest Headlines

More Articles About ATRC →

Company On Twitter

Company Profile

AtriCure, Inc. develops, manufactures, and sells surgical devices designed to create precise lesions in soft tissues. The Company's bipolar ablation system is used by cardiothoracic surgeons as a standard treatment alternative to create lesions in heart tissue to block the abnormal electrical impulses that cause atrial fibrillation.


Investor Relations | Press Releases

Insider Trading Cheat Sheet

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lucky James L VP, Clinical, Regulatory & QS Mar 06 Sale 8.22 4,616 37,944 51,250 Mar 07 12:11 PM
Lucky James L VP, Clinical, Regulatory & QS Mar 05 Option Exercise 5.08 54,922 279,236 77,893 Mar 07 12:11 PM
Lucky James L VP, Clinical, Regulatory & QS Mar 05 Sale 8.13 45,449 369,500 46,393 Mar 07 12:11 PM
Discovery Group I, LLC 10% Owner Dec 17 Sale 6.53 10,000 65,330 1,621,334 Dec 19 06:52 PM
Discovery Group I, LLC 10% Owner Dec 13 Sale 6.36 19,934 126,693 1,674,768 Dec 13 05:35 PM
Discovery Group I, LLC 10% Owner Dec 12 Sale 6.13 13,500 82,750 1,694,702 Dec 13 05:35 PM
Discovery Group I, LLC 10% Owner Dec 11 Sale 6.11 19,800 120,968 1,708,202 Dec 13 05:35 PM
Discovery Group I, LLC 10% Owner Dec 10 Sale 6.10 6,035 36,842 1,728,002 Dec 10 05:06 PM
Discovery Group I, LLC 10% Owner Dec 06 Sale 6.21 8,558 53,187 1,751,337 Dec 10 05:06 PM
Discovery Group I, LLC 10% Owner Dec 04 Sale 6.50 29,700 193,050 202,880 Dec 04 05:36 PM
Yahoo, HV, Market Watch, The Wall St. Journal